ERBB2 and breast neoplasm: Previous studies have shown that a high level of BAZ1A in HER2+ breast tumors is associated with poor overall survival and relapse-free survival, and amplification of Bromodomain PHD Finger Transcription Factor (BPTF) in breast tumors is linked to short metastasis-free survival (Pérez-Pena et al., 2019; Li et al., 2021).